Techcyte Raises $15M in Funding Led by Van Tuyl Companies

This funding strengthens Techcytes ability to execute its strategy and move toward profitability. Its veterinary segment is already profitable, and the company expects its environmental and human health businesses to reach profitability next year. This progress comes as labs face growing pressure to deliver accurate results despite limited resources, higher testing volumes and staff shortages.

At the same time, digital pathology is becoming a key way to improve efficiency, and expand access to diagnostic expertise through remote workflows. Techcytes Fusion platform supports this shift by combining AI, digital workflows and integration with lab systems to streamline case reviews and scale operations.

To further advance these capabilities the funding also provides access to Mayo Clinic’s Safe Harbor dataset which includes over 17 million de-identified slides and reports. This data will help strengthen Techcytes AI and improve the performance of its Fusion platform.

Read More:Photon Raises $16M in Series A Funding Led by Healthier Capital

By using AI in everyday diagnostic workflows, Techcyte helps labs deliver faster, more consistent, and more accessible results across different healthcare settings.

“Laboratories are being asked to do more with less, while maintaining high standards for quality and rapid turnaround times,” said Ben Cahoon, CEO of Techcyte. “Techcyte Fusion® directly addresses these challenges through unified AI-enabled pathology workflows. This investment allows us to continue growing the Fusion platform and to extend the world-class capabilities built in collaboration with Mayo Clinic. We are grateful to Van Tuyl Companies for leading this round and to Mayo Clinic and Zoetis for their continued collaboration and support.”

About Techcyte

Founded in 2013 Techcyte is improving pathology with an AI powered digital platform that simplifies workflows, connects with lab systems and improves communication. By working with leading labs, hardware providers, and AI developers, the company delivers a unified digital pathology solution to clinics worldwide, supporting better health for humans, animals, and the environment.

Read More:DISA Technologies Raises $33M in Funding